TFE3 and renal carcinoma: Accordingly, mTORC1 inhibition or silencing of TFE3 or Rag D reduces mTORC1 activity and proliferation of renal cancer cells expressing TFE3 fusions (Di Malta et al., 2017; Damayanti et al., 2018).